Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/19055Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bowyer, Samantha | - |
| dc.contributor.author | Prithviraj, Prashanth | - |
| dc.contributor.author | Lorigan, Paul | - |
| dc.contributor.author | Larkin, James | - |
| dc.contributor.author | McArthur, Grant | - |
| dc.contributor.author | Atkinson, Victoria | - |
| dc.contributor.author | Millward, Michael | - |
| dc.contributor.author | Khou, Muoi | - |
| dc.contributor.author | Diem, Stefan | - |
| dc.contributor.author | Ramanujam, Sangeetha | - |
| dc.contributor.author | Kong, Ben | - |
| dc.contributor.author | Liniker, Elizabeth | - |
| dc.contributor.author | Guminski, Alexander | - |
| dc.contributor.author | Parente, Phillip | - |
| dc.contributor.author | Andrews, Miles C | - |
| dc.contributor.author | Parakh, Sagun | - |
| dc.contributor.author | Cebon, Jonathan S | - |
| dc.contributor.author | Long, Georgina V | - |
| dc.contributor.author | Carlino, Matteo S | - |
| dc.contributor.author | Klein, Oliver | - |
| dc.date | 2017-03-21 | - |
| dc.date.accessioned | 2018-09-13T00:14:46Z | - |
| dc.date.available | 2018-09-13T00:14:46Z | - |
| dc.date.issued | 2017-04-11 | - |
| dc.identifier.citation | British Journal of Cancer 2017; 116(8): e15 | - |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/19055 | - |
| dc.language.iso | eng | - |
| dc.title | Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''. | - |
| dc.type | Journal Article | - |
| dc.identifier.journaltitle | British Journal of Cancer | - |
| dc.identifier.affiliation | The Christie NHS Foundation Trust and University of Manchester, Manchester, UK | en |
| dc.identifier.affiliation | Royal Marsden Hospital NHS Foundation Trust, London, UK | en |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia | en |
| dc.identifier.affiliation | University of Sydney, Sydney, New South Wales, Australia | en |
| dc.identifier.affiliation | Box Hill Hospital, Melbourne, Victoria, Australia | en |
| dc.identifier.affiliation | Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia | en |
| dc.identifier.affiliation | Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia | en |
| dc.identifier.affiliation | Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia | en |
| dc.identifier.affiliation | Melanoma Institute Australia, Sydney, New South Wales, Australia | en |
| dc.identifier.affiliation | Department of Medical Oncology, Olivia Newton John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia | en |
| dc.identifier.affiliation | School of Medicine and Pharmacology, University of Western Australia, Australia, Nedlands, Western Australia, Australia | en |
| dc.identifier.affiliation | Rockingham General Hospital, Perth, Western Australia, Australia | en |
| dc.identifier.affiliation | Westmead Hospital, Sydney, New South Wales, Australia | en |
| dc.identifier.doi | 10.1038/bjc.2017.59 | - |
| dc.identifier.pubmedid | 28324885 | - |
| dc.type.austin | Journal Article | - |
| local.name.researcher | Cebon, Jonathan S | |
| item.cerifentitytype | Publications | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | No Fulltext | - |
| item.openairetype | Journal Article | - |
| item.grantfulltext | none | - |
| item.languageiso639-1 | en | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
| crisitem.author.dept | Medical Oncology | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.